PR Newswire – Page 437

Brand Post April 14, 2025

IDEAYA Biosciences Announces Successful FDA Type D Meeting on Phase 3 Registrational Trial Design for Darovasertib as Neoadjuvant Therapy for Primary Uveal Melanoma

Targeting to initiate Phase 3 randomized registrational trial for darovasertib in the neoadjuvant setting in primary UM in H1 2025…

Brand Post April 14, 2025

VANCOUVER, BC, April 14, 2025 /PRNewswire/ – GoldMining Inc. (the “Company” or “GoldMining“) (TSX: GOLD) (NYSE American: GLDG) is pleased…

Brand Post April 14, 2025

LONDON, April 14, 2025 /PRNewswire/ — Today marks the official launch of EX3, a bold new identity born from the…

Brand Post April 13, 2025

BEIJING, April 13, 2025 /PRNewswire/ — General Secretary of the Communist Party of China (CPC) Central Committee and Chinese President Xi…

Brand Post April 13, 2025

SHENZHEN, China, April 13, 2025 /PRNewswire/ — MGI Tech Co., Ltd. (“MGI”), a company committed to building core tools and…

Brand Post April 13, 2025

SHANGHAI, April 13, 2025 /PRNewswire/ — The 91st China International Medical Equipment Fair (CMEF) concluded on April 11, 2025, in…

Brand Post April 13, 2025

NEW YORK, April 13, 2025 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities…

Brand Post April 13, 2025

NEW YORK, April 13, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities…

Brand Post April 13, 2025

NEW YORK, April 13, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities…

Brand Post April 13, 2025

RIYADH, Saudi Arabia, April 13, 2025 /PRNewswire/ — The Human Capability Development Program (HCDP), a Saudi Vision 2030 Realization Program,…